Global Plasma Therapy Market Size, Status and Forecast 2019-2025

Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered
• 1.4 Market Analysis by Type
  • 1.4.1 Global Plasma Therapy Market Size Growth Rate by Type (2014-2025)
  • 1.4.2 Pure PRP
  • 1.4.3 Leucocyte-rich PRP
  • 1.4.4 Pure Platelet-rich Fibrin (PRF)
  • 1.4.5 Leukocyte-rich Fibrin (L-PRF)
• 1.5 Market by Application
  • 1.5.1 Global Plasma Therapy Market Share by Application (2014-2025)
  • 1.5.2 Orthopedics
  • 1.5.3 Dermatology
  • 1.5.4 Dental
  • 1.5.5 Cardiac Muscle Injury
  • 1.5.6 Nerve Injury
  • 1.5.7 Others
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Plasma Therapy Market Size
• 2.2 Plasma Therapy Growth Trends by Regions
  • 2.2.1 Plasma Therapy Market Size by Regions (2014-2025)
  • 2.2.2 Plasma Therapy Market Share by Regions (2014-2019)
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Opportunities

3 Market Share by Key Players

• 3.1 Plasma Therapy Market Size by Manufacturers
  • 3.1.1 Global Plasma Therapy Revenue by Manufacturers (2014-2019)
  • 3.1.2 Global Plasma Therapy Revenue Market Share by Manufacturers (2014-2019)
  • 3.1.3 Global Plasma Therapy Market Concentration Ratio (CR5 and HHI)
• 3.2 Plasma Therapy Key Players Head office and Area Served
• 3.3 Key Players Plasma Therapy Product/Solution/Service
• 3.4 Date of Enter into Plasma Therapy Market
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application

• 4.1 Global Plasma Therapy Market Size by Type (2014-2019)
• 4.2 Global Plasma Therapy Market Size by Application (2014-2019)

5 United States

• 5.1 United States Plasma Therapy Market Size (2014-2019)
• 5.2 Plasma Therapy Key Players in United States
• 5.3 United States Plasma Therapy Market Size by Type
• 5.4 United States Plasma Therapy Market Size by Application

6 Europe

• 6.1 Europe Plasma Therapy Market Size (2014-2019)
• 6.2 Plasma Therapy Key Players in Europe
• 6.3 Europe Plasma Therapy Market Size by Type
• 6.4 Europe Plasma Therapy Market Size by Application

7 China

• 7.1 China Plasma Therapy Market Size (2014-2019)
• 7.2 Plasma Therapy Key Players in China
• 7.3 China Plasma Therapy Market Size by Type
• 7.4 China Plasma Therapy Market Size by Application

8 Japan

• 8.1 Japan Plasma Therapy Market Size (2014-2019)
• 8.2 Plasma Therapy Key Players in Japan
• 8.3 Japan Plasma Therapy Market Size by Type
• 8.4 Japan Plasma Therapy Market Size by Application

9 Southeast Asia

• 9.1 Southeast Asia Plasma Therapy Market Size (2014-2019)
• 9.2 Plasma Therapy Key Players in Southeast Asia
• 9.3 Southeast Asia Plasma Therapy Market Size by Type
• 9.4 Southeast Asia Plasma Therapy Market Size by Application

10 India

• 10.1 India Plasma Therapy Market Size (2014-2019)
• 10.2 Plasma Therapy Key Players in India
• 10.3 India Plasma Therapy Market Size by Type
• 10.4 India Plasma Therapy Market Size by Application

11 Central & South America

• 11.1 Central & South America Plasma Therapy Market Size (2014-2019)
• 11.2 Plasma Therapy Key Players in Central & South America
• 11.3 Central & South America Plasma Therapy Market Size by Type
• 11.4 Central & South America Plasma Therapy Market Size by Application

12 International Players Profiles

• 12.1 BiolifePlasmaServices
  • 12.1.1 BiolifePlasmaServices Company Details
  • 12.1.2 Company Description and Business Overview
  • 12.1.3 Plasma Therapy Introduction
  • 12.1.4 BiolifePlasmaServices Revenue in Plasma Therapy Business (2014-2019)
  • 12.1.5 BiolifePlasmaServices Recent Development
• 12.2 CambrynBiologicsLLC
  • 12.2.1 CambrynBiologicsLLC Company Details
  • 12.2.2 Company Description and Business Overview
  • 12.2.3 Plasma Therapy Introduction
  • 12.2.4 CambrynBiologicsLLC Revenue in Plasma Therapy Business (2014-2019)
  • 12.2.5 CambrynBiologicsLLC Recent Development
• 12.3 Biotest
  • 12.3.1 Biotest Company Details
  • 12.3.2 Company Description and Business Overview
  • 12.3.3 Plasma Therapy Introduction
  • 12.3.4 Biotest Revenue in Plasma Therapy Business (2014-2019)
  • 12.3.5 Biotest Recent Development
• 12.4 CSLLtd.
  • 12.4.1 CSLLtd. Company Details
  • 12.4.2 Company Description and Business Overview
  • 12.4.3 Plasma Therapy Introduction
  • 12.4.4 CSLLtd. Revenue in Plasma Therapy Business (2014-2019)
  • 12.4.5 CSLLtd. Recent Development
• 12.5 GrifolsInternationalS.A.
  • 12.5.1 GrifolsInternationalS.A. Company Details
  • 12.5.2 Company Description and Business Overview
  • 12.5.3 Plasma Therapy Introduction
  • 12.5.4 GrifolsInternationalS.A. Revenue in Plasma Therapy Business (2014-2019)
  • 12.5.5 GrifolsInternationalS.A. Recent Development
• 12.6 KedrionS.P.A.
  • 12.6.1 KedrionS.P.A. Company Details
  • 12.6.2 Company Description and Business Overview
  • 12.6.3 Plasma Therapy Introduction
  • 12.6.4 KedrionS.P.A. Revenue in Plasma Therapy Business (2014-2019)
  • 12.6.5 KedrionS.P.A. Recent Development
• 12.7 LFBSA
  • 12.7.1 LFBSA Company Details
  • 12.7.2 Company Description and Business Overview
  • 12.7.3 Plasma Therapy Introduction
  • 12.7.4 LFBSA Revenue in Plasma Therapy Business (2014-2019)
  • 12.7.5 LFBSA Recent Development
• 12.8 BioProductLaboratoryLtd.(BPL)
  • 12.8.1 BioProductLaboratoryLtd.(BPL) Company Details
  • 12.8.2 Company Description and Business Overview
  • 12.8.3 Plasma Therapy Introduction
  • 12.8.4 BioProductLaboratoryLtd.(BPL) Revenue in Plasma Therapy Business (2014-2019)
  • 12.8.5 BioProductLaboratoryLtd.(BPL) Recent Development
• 12.9 ChinaBiologicProducts,Inc.
  • 12.9.1 ChinaBiologicProducts,Inc. Company Details
  • 12.9.2 Company Description and Business Overview
  • 12.9.3 Plasma Therapy Introduction
  • 12.9.4 ChinaBiologicProducts,Inc. Revenue in Plasma Therapy Business (2014-2019)
  • 12.9.5 ChinaBiologicProducts,Inc. Recent Development
• 12.10 Octapharma
  • 12.10.1 Octapharma Company Details
  • 12.10.2 Company Description and Business Overview
  • 12.10.3 Plasma Therapy Introduction
  • 12.10.4 Octapharma Revenue in Plasma Therapy Business (2014-2019)
  • 12.10.5 Octapharma Recent Development

13 Market Forecast 2019-2025

• 13.1 Market Size Forecast by Regions
• 13.2 United States
• 13.3 Europe
• 13.4 China
• 13.5 Japan
• 13.6 Southeast Asia
• 13.7 India
• 13.8 Central & South America
• 13.9 Market Size Forecast by Product (2019-2025)
• 13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
    • 15.1.1.1 Research Programs/Design
    • 15.1.1.2 Market Size Estimation
    • 12.1.1.3 Market Breakdown and Data Triangulation
  • 15.1.2 Data Source
    • 15.1.2.1 Secondary Sources
    • 15.1.2.2 Primary Sources
• 15.2 Disclaimer